NEOFORDEX

EUIPO EUIPO 2010 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark NEOFORDEX was filed as Word mark on 11/18/2010 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/02/2011. The current status of the mark is "Trademark registered".

Trademark Details Last update: October 15, 2024

Trademark form Word mark
File reference 009568205
Application date November 18, 2010
Publication date January 21, 2011
Entry date May 2, 2011
Expiration date November 18, 2030

Trademark owner

16 Rue Montrosier
92200 Neuilly-sur-Seine
FR

Trademark representatives

83 Avenue Denfert-Rochereau 75014 PARIS FR

goods and services

5 Pharmaceutical and veterinary products for the treatment of chronic diseases; Pharmaceutical and veterinary products for the treatment of proliferative diseases; Chemical compounds for medical or pharmaceutical purposes; Product for the treatment of rheumatological diseases; Product for the treatment of diseases in the area of oncology, in particular the treatment of cancer, specifically cancer of the colon, cancer of the rectum, breast cancer, prostate cancer, cancer of the pancreas, stomach cancer, cancer of the thyroid, cancer of the larynx, cancer of the liver, cancer of the uterus, cancer of the cervix, cancer of the oesophagus, cancer of the ovaries, lung cancer, pleural cancer, cancer of the mouth and the larynx, kidney cancer, bladder cancer, cancer of the testicles, melanoma, lymphatic cancer, hematopoietic cancer, carcinomas, sarcomas, cancer of the nervous system, particularly primitive tumours of the central nervous system; Product for the treatment of diseases within the area of onco-haematology, in particular lymphomas, specifically Hodgkin's Disease and non-Hodgkin's lymphomas, adenopathies, myelomas, particularly multiple myelomas and leukaemias; Product for the treatment of haematological diseases, particularly amyloidosis and purpura, especially thrombopaenic purpura
42 Scientific research in the medical field, particularly in the areas of oncology, haematology and rheumatology; Research and development of new products (for others); Computer services, namely computer-aided data analysis

Trademark history

Date Document number Area Entry
July 16, 2024 Transfer / Change of address, Published
January 26, 2021 Extension, Trade mark renewed
October 16, 2019 Change Representative, Published
October 7, 2015 Change Representative, Published
February 4, 2014 Change Representative, Published
January 31, 2014 Transfer / Change of address, Published

ID: 11009568205